TFEB and TFE3 have cell-type specific expression in the brain and divergent roles in neurons
McGuinness, W.; Ryan, B. J.; Guardado, C. L.; Carling, P.; Vallin, B.; Caiazza, M. C.; Heon-Roberts, R.; Kilfeather, P.; Wantling, J.; Hoffmann, J.; Aird, D.; Lofstromm, K.; Zhang, M.; Cowley, S. A.; Hirst, W. D.; Wade-Martins, R.
Show abstract
Lysosomal dysfunction occurs in many neurodegenerative diseases, including Parkinsons disease, and activating TFEB to enhance lysosomal biogenesis is a promising therapeutic strategy. To understand TFEB physiology in cells of the brain, we characterised TFEB expression using iPSC-derived models, and transcriptomic analysis of human and mouse brain tissue. Surprisingly, TFEB expression at the RNA and protein level was restricted to glia, whereas the related transcription factor, TFE3, was expressed ubiquitously. We identified HDAC1/2/3 as transcriptional repressors of neuronal TFEB and found the brain-penetrant HDAC inhibitor ACY-738 derepressed TFEB expression and enhanced TFE3 nuclear translocation in iPSC-dopaminergic neurons (iPSC-DaNs). We delineated the role of each transcription factor by genetic manipulation in iPSC-DaNs to reveal divergent roles in which TFEB activates mitochondrial biogenesis, whereas TFE3 enhances lysosomal biogenesis. Finally, we show TFE3 activation corrects the lysosomal dysfunction associated with GBA-N370S and SNCA-Triplication mutations in Parkinsons patient-derived iPSC-DaNs, demonstrating therapeutic utility in neurodegeneration.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Mutant Huntingtin impairs neurodevelopment in human brain organoids through CHCHD2-mediated neurometabolic failure 96%
- Circular RNAs in the human brain are tailored to neuron identity and neuropsychiatric disease 96%
- ZMYND11 Functions in Bimodal Regulation of Latent Genes and Brain-like Splicing to Safeguard Corticogenesis 96%
Similar papers in this journal
- A Mitochondrial Inside-Out Iron-Calcium Signal Reveals Drug Targets for Parkinsons Disease 96%
- Single cell spatial transcriptomic and translatomic profiling of dopaminergic neurons in health, aging and disease 96%
- Drug-induced eRF1 degradation promotes readthrough and reveals a new branch of ribosome quality control 96%
Similar papers in this journal
- Glucosylceramide induced ectosomes propagate pathogenic α-synuclein in Parkinson's disease 97%
- Heat shock chaperone HSPB1 regulates cytoplasmic TDP-43 phase separation and liquid-to-gel transition 94%
- BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2 94%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.